NTx's mission is to revolutionize the management of complex medical conditions with the next generation of integrated therapeutic products. Despite massive investment in research and development, there has been relatively little progress towards improving clinical outcomes for patients with complex medical conditions, including traumatic brain injury, Alzheimer's disease, autism, and many others. We finally understand why decades of excellent science has not efficiently translated into better clinical outcomes. Part of the answer is emerging from big-data. Cognitive computing has helped us to resolve the massively complex biomedical mechanisms underlying these challenging complex medical conditions, and these new insights are revealing a previously unrecognized need for multi-scalar approaches that intelligently integrate multimodal interventions. In other words, the computational modeling of complex mechanisms can be used to design more sophisticated approaches that address different dimensions of the disease at the same time. This is achieved by intelligently combining pharmacological interventions to act at the molecular scale, nanoparticles that act at the sub-cellular level, and devices that operate at the organ level. Armed with the power to design this next generation of integrated therapeutic solutions, NTx is taking a radically new approach to therapeutic product development. The first multi-scalar solution NTx is developing combines pharmacological agents, nanoparticles, and an innovative surgical device, which are intelligently integrated to provide a true breakthrough solution for medically managing traumatic brain injury (TBI). Technologically, this next generation approach to combine pharmaceutical, nanoparticle, and device interventions into a single integrated multi-scalar therapeutic product is potentially transformative and represents an unprecedented opportunity to improve outcomes for patients. To realize this mission, we have assembled a multidisciplinary team that is uniquely qualified to successfully drive this new paradigm, and in doing so, to revolutionize the entire field. NTx's founders are experienced biotech executives, scientific thought leaders and clinical innovators, all driven with a singular passion - to improve outcomes for patients.

Website: http://www.ntx.ai

Employees: 5

HQ:

Location: Orange, California, United States

Revenue: